Copy

Join us on October 19th for an exciting program on translational science and entrepreneurship focused on the microbiome, neuroscience, oncology, and novel platforms.

Submit Poster
Register

09.00

Registration - Posters

09.30

Welcome
Dr. William Hait, Global Head Janssen R&D
Kurt Hertogs, Head Johnson & Johnson Innovation, JLINX
Tom Aelbrecht, Head Janssen Campus Office

09.45

Dr. Dirk Gevers
Global Head, Janssen Human Microbiome Institute, JHMI

10.10

Prof. dr. Max Nieuwdorp
Academic Medical Centre, VU University Medical Centre, Amsterdam

10.30

JLINX Boot Camp participant

10.45

Prof. dr. Bart De Strooper
VIB Centre for the Biology of the Disease, University of Leuven

11.10

Dr. Xavier Jacq
Co-Founder Camphos Therapeutics, Cambridge

11.35

Prof. dr. Markus Kleinewietfeld
VIB Laboratory of Translational Immunomodulation, Hasselt University

11.55

JLINX Boot Camp participant

12.10

Lunch – Posters

13.45

Dr. Thijn Brummelkamp
Group leader, Netherlands Cancer Institute, Amsterdam

14.05

Dr. Peter Fraser
Head of the Nuclear Dynamics Programme,
The Babraham Institute, Cambridge

14.30

JLINX Boot Camp participant

14.45

JLINX Boot Camp participant

15.00

Prof. Diether Lambrechts
Vesalius Research Centre, VIB, KU Leuven

15.20

Dr. Peter De Keizer
Group Leader, Erasmus University Medical Centre Rotterdam

15.40

JLINX Boot Camp participant

16.15

Award ceremony and closing remarks
Dr. Paul Stoffels, CSO Johnson & Johnson
Nico Vandervelpen, Managing Director and Cofounder, Bioqube Ventures

16.30

Reception

Johnson & Johnson Innovation, JLINX is a multifaceted initiative in Europe designed to identify and nurture early-stage companies who are actively pursuing research with the potential to transform human health.

©Johnson & Johnson Innovation LLC 2016. All Rights Reserved.